Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters











Publication year range
1.
Int J Pharm ; 515(1-2): 774-787, 2016 Dec 30.
Article in English | MEDLINE | ID: mdl-27826027

ABSTRACT

The objective of this study was to evaluate five commercial ready-to-use transdermal vehicles (Phytobase®, Lipovan®, Pentravan®, Pentravan® Plus and Pluronic Lecithin Organogel (PLO)), for the compounding of three antiemetic drugs (ondansetron, dexamethasone and aprepitant) and their administration in combination to treat chemotherapy-induced nausea and vomiting (CINV) at the hospital. Drugs were individually formulated in these vehicles and in mixture in Pentravan® Plus using different penetration enhancers. Quality control of the forms has demonstrated that formulation process was mastered and convenient for the hospital (time required: 20min). Diffusion experiments through synthetic membranes and pig ear epidermis performed using Franz-type diffusion cells, have shown that the release and permeation process were greater for ondansetron than for dexamethasone and aprepitant, with a release step not limiting. As permeation of aprepitant was too low, it was discarded of the study. When ondansetron and dexamethasone were compounded in combination in Pentravan® Plus, the most efficient vehicle, a permeation decrease was observed. Finally, the use of tween 20 instead of EtOH as chemical enhancer has led to 2-fold factor increase in the flux of dexamethasone, resulting in fluxes convenient for transdermal administration of ondansetron to a child, but insufficient for an adult and for dexamethasone.


Subject(s)
Antiemetics/chemistry , Antineoplastic Agents/adverse effects , Lecithins/chemistry , Nausea/drug therapy , Pharmaceutical Vehicles/chemistry , Vomiting/drug therapy , Administration, Cutaneous , Animals , Antiemetics/administration & dosage , Aprepitant , Chemistry, Pharmaceutical/methods , Dexamethasone/chemistry , Drug Carriers/chemistry , Humans , Morpholines/chemistry , Nausea/chemically induced , Ondansetron/chemistry , Swine , Vomiting/chemically induced
2.
Dev Biol ; 278(2): 560-75, 2005 Feb 15.
Article in English | MEDLINE | ID: mdl-15680370

ABSTRACT

We have performed a detailed analysis of the expression pattern of the three gnathostome Otx classes in order to gain new insights into their functional evolution. Expression patterns were examined in the developing eye of a chondrichthyan, the dogfish, and an amniote, the chick, and compared with the capacity of paralogous proteins to induce a pigmented phenotype in cultured retina cells in cooperation with the bHLH-leucine zipper protein Mitf. This analysis indicates that each Otx class is characterized by highly specific and conserved expression features in the presumptive RPE, where Otx1 and Otx2, but not Otx5, are transcribed at optic vesicle stages, in the differentiating neural retina, where Otx2 and Otx5 show a conserved dynamic expression pattern, and in the forming ciliary process, a major site of Otx1 expression. Furthermore, the paralogous proteins of the dogfish and the mouse do not display any significant difference in their capacity to induce a pigmented phenotype, suggesting a functional equivalency in the specification and differentiation of the RPE. These data indicate that specific functions selectively involving each Otx orthology class were fixed prior to the gnathostome radiation and highlight the prominent role of regulatory changes in the functional diversification of the multigene family.


Subject(s)
Chickens/genetics , Dogfish/genetics , Eye/embryology , Gene Expression Regulation, Developmental , Retina/embryology , Animals , Body Patterning , Cell Differentiation , Chick Embryo/physiology , Dogfish/embryology , Embryo, Nonmammalian/physiology , Gastrula/physiology , Homeodomain Proteins , Mice , Multigene Family , Otx Transcription Factors , Transcriptional Activation
3.
J Biol Chem ; 276(38): 35751-60, 2001 Sep 21.
Article in English | MEDLINE | ID: mdl-11457839

ABSTRACT

In the endocrine pancreas, alpha-cell-specific expression of the glucagon gene is mediated by DNA-binding proteins that interact with the G1 proximal promoter element. Among these proteins, the paired domain transcription factor Pax-6 has been shown to bind to G1 and to transactivate glucagon gene expression. Close to the Pax-6-binding site, we observed the presence of a binding site for a basic leucine zipper transcription factor of the Maf family. In the present study, we demonstrate the presence of Maf family members in the endocrine pancreas that bind to G1 and transactivate glucagon promoter expression. In transient transfection experiments, we found that the transactivating effect on the glucagon promoter was greatly enhanced by the simultaneous expression of Maf transcription factors and Pax-6. This enhancement on glucagon transactivation could be correlated with the ability of these proteins to interact together but does not require binding of Maf proteins to the G1 element. Furthermore, we found that Maf enhanced the Pax-6 DNA binding capacity. Our data indicate that Maf transcription factors may contribute to glucagon gene expression in the pancreas.


Subject(s)
DNA-Binding Proteins/metabolism , Glucagon/genetics , Homeodomain Proteins/metabolism , Promoter Regions, Genetic , Proto-Oncogene Proteins/metabolism , Transcription Factors/metabolism , Animals , Base Sequence , Cell Line , Cricetinae , DNA/metabolism , DNA Primers , Eye Proteins , PAX6 Transcription Factor , Paired Box Transcription Factors , Protein Binding , Proto-Oncogene Proteins c-maf , Repressor Proteins , Reverse Transcriptase Polymerase Chain Reaction , Transcriptional Activation
4.
J Biol Chem ; 276(31): 29330-7, 2001 Aug 03.
Article in English | MEDLINE | ID: mdl-11350962

ABSTRACT

Pax-6 and microphthalmia transcription factor (Mitf) are required for proper eye development. Pax-6, expressed in both the neuroretina and pigmented retina, has two DNA-binding domains: the paired domain and the homeodomain. Mice homozygous for Pax-6 mutations are anophthalmic. Mitf, a basic helix-loop-helix leucine zipper (b-HLH-LZ) transcription factor associated with the onset and maintenance of pigmentation, identifies the retinal pigmented epithelium during eye development. Loss of Mitf function results in the formation of an ectopic neuroretina at the expense of the dorsal retinal pigmented epithelium. In the present study, we investigated the interaction between Pax-6 and Mitf. In transient transfection-expression experiments, we found that transactivating effects of Pax-6 and Mitf on their respective target promoters were strongly inhibited by co-transfection of both transcription factors. This repression was due to direct protein/protein interactions involving both Pax-6 DNA-binding domains and the Mitf b-HLH-LZ domain. These results suggest that Pax-6/Mitf interactions may be critical for retinal pigmented epithelium development.


Subject(s)
DNA-Binding Proteins/metabolism , Homeodomain Proteins/metabolism , Pigment Epithelium of Eye/physiology , Transcription, Genetic , Animals , Base Sequence , Binding Sites , Cell Line , Cell Nucleus/metabolism , Cell Nucleus/ultrastructure , Cricetinae , DNA Probes , DNA-Binding Proteins/chemistry , DNA-Binding Proteins/genetics , Eye Proteins , Genes, Reporter , Green Fluorescent Proteins , Helix-Loop-Helix Motifs , Homeodomain Proteins/chemistry , Homeodomain Proteins/genetics , Homozygote , Leucine Zippers , Luminescent Proteins/analysis , Luminescent Proteins/genetics , Mice , Microphthalmia-Associated Transcription Factor , PAX6 Transcription Factor , Paired Box Transcription Factors , Pigment Epithelium of Eye/cytology , Pigment Epithelium of Eye/growth & development , Protein Biosynthesis , Quail , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/metabolism , Repressor Proteins , Restriction Mapping , Transcription Factors/chemistry , Transcription Factors/genetics , Transcription Factors/metabolism , Transfection
5.
Invest Ophthalmol Vis Sci ; 41(3): 917-26, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10711714

ABSTRACT

PURPOSE: To determine whether alterations in rod cGMP-gated channel function mediate retinal degeneration, a transgenic approach in which the alpha subunit of the rod cGMP-gated channel is reduced by the expression of an antisense RNA was used. METHODS: A 890-bp fragment of the 5' mouse rod cGMP-gated channel cDNA was cloned in the antisense orientation under the control of the strong bacterial cytomegalovirus promoter. This antisense construct was used to generate transgenic mice in which the expression of the antisense transgene was measured by reverse transcription-polymerase chain reaction. Histologic, immunocytochemical, and TdT-dUTP terminal nick-end labeling (TUNEL) analyses were performed on control and transgenic retina sections to determine the effects of antisense expression on specific cell types. RESULTS: The antisense RNA was able to inhibit the translation of the rod channel protein in an in vitro assay. Three transgenic mouse lines expressing the antisense construct were obtained. Molecular analyses showed that the antisense is expressed in the eye of each transgenic mouse line, where it reduces rod cGMP-gated channel RNA expression. Histologic and immunocytochemical data showed that transgenic retinas have a reduced number of photoreceptors and bipolar cells. TUNEL staining confirmed that photoreceptor and bipolar cells degenerate along an apoptotic pathway. CONCLUSIONS: Impairment of rod cGMP-gated channel alpha subunit expression leads to photoreceptor and bipolar cell degeneration. These transgenic mice are the first model of retinal degeneration caused by an alteration in the expression of the rod cGMP-gated channel. This model system can be used to test therapies designed to slow or stalled retinal degenerations.


Subject(s)
Cyclic GMP/genetics , Eye Proteins/genetics , Interneurons/pathology , Ion Channels/genetics , Photoreceptor Cells, Vertebrate/pathology , RNA/metabolism , Retinal Degeneration/genetics , Animals , Apoptosis/genetics , Blotting, Northern , Cyclic GMP/metabolism , Cyclic Nucleotide-Gated Cation Channels , Eye Proteins/metabolism , Gene Expression , In Situ Nick-End Labeling , Interneurons/metabolism , Ion Channels/metabolism , Mice , Mice, Transgenic , Photoreceptor Cells, Vertebrate/metabolism , RNA, Antisense/metabolism , Retinal Degeneration/metabolism , Retinal Degeneration/pathology , Retinal Rod Photoreceptor Cells/metabolism , Retinal Rod Photoreceptor Cells/pathology , Reverse Transcriptase Polymerase Chain Reaction
6.
Prog Neurobiol ; 56(1): 37-64, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9723130

ABSTRACT

Most functional studies of cyclic nucleotide-gated (CNG) channels have been confined to photoreceptors and olfactory epithelium, in which CNG channels are abundant and easy to study. The widespread distribution of CNG channels in tissues throughout the body has only recently been recognized and the functions of this channel family in many of these tissues remain largely unknown. The molecular biological and pharmacological properties of the CNG channel family are summarized in order to put in context studies aimed at probing CNG channel functions in these tissues using pharmacological and genetic methods. Compounds have now been identified that are useful in distinguishing CNG channel activated pathways from cAMP/cGMP dependent-protein kinases or other pathways. The ways in which these interact with CNG channels are understood and this knowledge is leading to the identification of more potent and more specific CNG channel subtype-specific agonists or antagonists. Recent molecular and genetic analyses have identified novel roles of CNG channels in neuronal development and plasticity in both invertebrates and vertebrates. Targeting CNG channels via specific drugs and genetic manipulation (such as knockout mice) will permit better understanding of the role of CNG channels in both basic and higher orders of brain function.


Subject(s)
Central Nervous System/physiology , Cyclic AMP-Dependent Protein Kinases/metabolism , Cyclic AMP/physiology , Cyclic GMP-Dependent Protein Kinases/metabolism , Cyclic GMP/physiology , Ion Channels/physiology , Animals , Humans , Invertebrates , Mice , Mice, Knockout , Neurons/physiology , Vertebrates
7.
J Neurochem ; 67(6): 2494-504, 1996 Dec.
Article in English | MEDLINE | ID: mdl-8931483

ABSTRACT

The Ret 1 element, located at -136 to -110 in the rat opsin promoter, binds developmentally regulated retinal nuclear proteins. A similar sequence is found up-stream of opsin genes, from humans to Drosophila, as well as many other photoreceptor-specific genes. The function of the Ret 1 element was tested both in vitro and in two sets of transgenic mice. A mutated Ret 1 element did not bind retinal nuclear proteins in vitro. The same mutations in an otherwise normal 1.9-kb rat opsin promoter failed to drive expression of a lacZ reporter gene in nine of 12 lines. In the three other lines, expression in photoreceptors was very faint. Four tandem copies of the Ret 1 element maintained the Ret 1 binding specificity in vitro and were able to direct expression of a lacZ transgene in photoreceptors of all nine mouse lines obtained. In two lines, expression was also detected in the ganglion cell layer and the ciliary epithelium. In three lines, a characteristic pattern of expression was found in the nervous system in addition to the normal retinal expression. These results indicate that Ret 1 can and is necessary to drive gene expression in rod photoreceptors. Furthermore, our results suggest that Ret 1-like elements may also be important in the developing nervous system.


Subject(s)
Promoter Regions, Genetic/genetics , Retinal Rod Photoreceptor Cells/physiology , Rod Opsins/genetics , Animals , Electrophoresis , Female , Gene Expression Regulation, Developmental/genetics , Genes, Reporter , Genetic Complementation Test , Lac Operon , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Mutagenesis/physiology , Nervous System/embryology , Nervous System Physiological Phenomena , Transcription Factors , Transgenes
8.
Brain Res Dev Brain Res ; 92(1): 1-9, 1996 Mar 29.
Article in English | MEDLINE | ID: mdl-8861716

ABSTRACT

Peripherin is a neuron-specific type III intermediate filament protein expressed in well-defined populations of neurons projecting towards peripheral targets. To investigate the molecular mechanisms by which a gene is expressed in a specific subset of neurons, we used a transgenic approach in order to define peripherin gene sequences that are necessary for cell-type specific expression. Transgenic mice carrying different various genomic regions of the mouse peripherin gene fused to the Escherichia coli lacZ reporter gene were generated. We used three different peripherin/lacZ constructs containing either 5.8 kb upstream sequences, or both 5.8 kb upstream and 1.1 kb intragenic sequences, or 1.1 kb intragenic sequences associated with an heterologous promoter. Analysis of lacZ gene expression in transgenic mouse embryos showed that cell type-specific expression of the mouse peripherin gene requires both upstream and intragenic sequences. Analysis of transgenic mouse lines expressing the construct containing both upstream and intragenic sequences showed that this transgene contains all regulatory elements essential for both spatial and temporal expression of the mouse peripherin gene during embryogenesis. Furthermore, lacZ+ positive cells isolated from these transgenic lines by fluorescence-activated cell sorting (FACS) can be stained with a peripherin antibody, demonstrating that the transgene containing both upstream and intragenic sequences is expressed in peripherin neurons. These mouse peripherin upstream and intragenic sequences can now be used to identify cis-acting regulatory elements and transcription factors involved in peripherin gene regulation.


Subject(s)
Embryo, Mammalian/physiology , Eye Proteins/genetics , Gene Expression , Intermediate Filament Proteins/genetics , Membrane Glycoproteins , Mice, Transgenic/genetics , Nerve Tissue Proteins , Neurons/physiology , Animals , Base Sequence , Cell Separation , Embryo, Mammalian/cytology , Flow Cytometry , Lac Operon , Mice/embryology , Molecular Sequence Data , Neurons/classification , Neuropeptides/genetics , Peripherins
9.
J Mol Neurosci ; 5(4): 273-95, 1994.
Article in English | MEDLINE | ID: mdl-7577369

ABSTRACT

Initial expression of the neurofilament light gene coincides with the appearance of postmitotic neurons. To investigate the molecular mechanisms involved in neuron-specific gene expression during embryogenesis, we generated transgenic mice carrying various regions of the human neurofilament light gene (hNF-L) fused to the lacZ reporter gene. We found that 2.3 or 0.3 kb of the hNF-L promoter region directs expression of lacZ in neurons of transgenic embryos. Addition of 1.8 kb hNF-L intragenic sequences (IS) enlarges the neuronal pattern of transgene expression. The 2.3-kb hNF-L promote lacZ-IS construct contains all regulatory elements essential for both spatial and temporal expression of the hNF-L gene during embryogenesis and in the adult. The use of a heterologous promoter demonstrated that the 1.8-kb hNF-L intragenic sequences are sufficient to direct the expression of lacZ in a NF-L-specific manner both temporally and spatially during development and in the adult. We conclude that these hNF-L intragenic sequences contain cis-acting DNA regulatory elements that specify neuronal expression. Taken together, these results show that the neurofilament light gene contains separate upstream and intragenic elements, each of which directs lacZ expression in embryonic neurons.


Subject(s)
Gene Expression Regulation, Developmental , Genes , Neurofilament Proteins/genetics , Neurons/metabolism , Recombinant Fusion Proteins/biosynthesis , Regulatory Sequences, Nucleic Acid , beta-Galactosidase/biosynthesis , Animals , Animals, Newborn , Base Sequence , Embryo, Mammalian/metabolism , Embryonic and Fetal Development/genetics , Female , Genes, Reporter , Humans , Immunoenzyme Techniques , Male , Mice , Mice, Inbred CBA , Mice, Transgenic , Molecular Sequence Data , Organ Specificity , Promoter Regions, Genetic
10.
J Physiol (Paris) ; 85(3): 117-22, 1991.
Article in English | MEDLINE | ID: mdl-1818107

ABSTRACT

In spite of considerable advances towards understanding lineages derived from neural crest cells using amphibian and avian embryos, the molecular mechanisms involved in the formation of mammalian peripheral ganglia remain largely unknown, mainly because of the lack of experimental systems that will allow their in vitro manipulation. Here, we present a novel mammalian in vitro model permitting to study gangliogenesis from neural crest cells. This model allowed us to manipulate molecules involved in cell-cell interactions. Our data are in favour of the existence of a hierarchy among adhesion molecules.


Subject(s)
Ganglia/embryology , Neural Crest/cytology , Animals , Cell Adhesion Molecules, Neuronal/physiology , Ganglia/cytology , Ganglia/physiology , In Vitro Techniques , Mice , Models, Neurological , Neural Crest/physiology , Neuraminidase/metabolism , Peripheral Nerves/embryology , Peripheral Nerves/physiology
11.
J Physiol (Paris) ; 84(1): 95-9, 1990.
Article in English | MEDLINE | ID: mdl-2193151

ABSTRACT

The molecular mechanisms involved in the formation of mammalian peripheral nervous system remain largely unknown. Here we describe the new possibilities offered by mouse mutant analysis, new mouse in vitro models and the recent development of molecular genetic techniques which may permit analysis of the peripheral nervous system development at a level that was heretofore restricted to lower vertebrates.


Subject(s)
Neural Crest/embryology , Peripheral Nerves/embryology , Animals , Cell Differentiation , Mice , Mice, Mutant Strains , Mice, Transgenic , Molecular Biology , Neural Crest/cytology
SELECTION OF CITATIONS
SEARCH DETAIL